SG11202006459XA - Proteinaceous molecules and uses therefor - Google Patents

Proteinaceous molecules and uses therefor

Info

Publication number
SG11202006459XA
SG11202006459XA SG11202006459XA SG11202006459XA SG11202006459XA SG 11202006459X A SG11202006459X A SG 11202006459XA SG 11202006459X A SG11202006459X A SG 11202006459XA SG 11202006459X A SG11202006459X A SG 11202006459XA SG 11202006459X A SG11202006459X A SG 11202006459XA
Authority
SG
Singapore
Prior art keywords
uses therefor
proteinaceous molecules
proteinaceous
molecules
therefor
Prior art date
Application number
SG11202006459XA
Other languages
English (en)
Inventor
Sudha Rao
Peter Milburn
Original Assignee
Epiaxis Therapeutics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018900108A external-priority patent/AU2018900108A0/en
Application filed by Epiaxis Therapeutics Pty Ltd filed Critical Epiaxis Therapeutics Pty Ltd
Publication of SG11202006459XA publication Critical patent/SG11202006459XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202006459XA 2018-01-15 2019-01-15 Proteinaceous molecules and uses therefor SG11202006459XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018900108A AU2018900108A0 (en) 2018-01-15 Proteinaceous molecules and uses therefor
PCT/AU2019/050024 WO2019136531A1 (fr) 2018-01-15 2019-01-15 Molécules protéiques et utilisations associées

Publications (1)

Publication Number Publication Date
SG11202006459XA true SG11202006459XA (en) 2020-08-28

Family

ID=67218182

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202006459XA SG11202006459XA (en) 2018-01-15 2019-01-15 Proteinaceous molecules and uses therefor

Country Status (8)

Country Link
US (1) US20200339691A1 (fr)
EP (1) EP3740496A4 (fr)
JP (1) JP2021510538A (fr)
CN (1) CN111936509A (fr)
AU (1) AU2019207534B2 (fr)
CA (1) CA3087761A1 (fr)
SG (1) SG11202006459XA (fr)
WO (1) WO2019136531A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210055302A1 (en) * 2018-01-15 2021-02-25 Epiaxis Therapeutics Pty Ltd Agents and methods for predicting response to therapy
AU2020340466A1 (en) * 2019-09-03 2022-03-24 The Council Of The Queensland Institute Of Medical Research Methods and agents for determining patient status
CN111411082B (zh) * 2020-03-26 2022-04-01 中山大学孙逸仙纪念医院 一种培养CD90posi细胞的培养基及其培养方法
KR20230146025A (ko) * 2021-01-19 2023-10-18 더 카운실 오브 더 퀸즐랜드 인스티튜트 오브 메디컬 리서치 신규 바이사이클릭 펩티드
CN112759626B (zh) * 2021-02-03 2022-10-14 安徽大学 一种核定位信号肽及其序列和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002328203C1 (en) * 2001-08-24 2009-01-08 Migenix Inc. Antimicrobial and anti-inflammatory peptides
WO2008021542A2 (fr) * 2006-08-17 2008-02-21 Cell Signaling Technology, Inc. Sites d'acétylation de la lysine
US20130017199A1 (en) * 2009-11-24 2013-01-17 AMPLIMMUNE ,Inc. a corporation Simultaneous inhibition of pd-l1/pd-l2
EP3290517B1 (fr) * 2015-04-30 2020-01-01 Kyoto University Procédé pour prévoir l'effet thérapeutique d'un inhibiteur de pd-1/pd-l1 en utilisant une anomalie dans pd-l1(cd274) comme indice
WO2017220602A1 (fr) * 2016-06-21 2017-12-28 Herlev Hospital Peptides pdl1 utilisés dans des vaccins contre le cancer

Also Published As

Publication number Publication date
JP2021510538A (ja) 2021-04-30
US20200339691A1 (en) 2020-10-29
CN111936509A (zh) 2020-11-13
AU2019207534B2 (en) 2022-06-09
EP3740496A4 (fr) 2021-12-08
EP3740496A1 (fr) 2020-11-25
WO2019136531A1 (fr) 2019-07-18
AU2019207534A1 (en) 2020-07-23
CA3087761A1 (fr) 2019-07-18

Similar Documents

Publication Publication Date Title
IL273432A (en) Protein compounds and their uses
EP3625358A4 (fr) Biomarqueurs et utilisations de ces derniers
IL281568A (en) Collagen-local immunomodulatory molecules and their use
GB202006164D0 (en) Recombinant collagen and eslastin molecules and uses thereof
EP3331549A4 (fr) Molécules améliorées aptes à se lier à des microbes, et leurs utilisations
SG11202006459XA (en) Proteinaceous molecules and uses therefor
ZA201900209B (en) Novel natural protein and application thereof
IL282362A (en) Intein proteins and their uses
EP3630732A4 (fr) Méthode et molécules
IL278832A (en) Improved molecules that bind 41GP
EP3312273A4 (fr) Étiquette induisant la dégradation des protéines et son utilisation
GB201707248D0 (en) Modified complement proteins and uses thereof
GB201812561D0 (en) Biomarkers and uses thereof
GB201806042D0 (en) Biomarkers and uses thereof
EP3515449A4 (fr) Inhibiteurs de protéine chromobox et leurs utilisations
EP3665283A4 (fr) Protéine tronquée résistante au chloramphénicol et ses utilisations
IL284781A (en) LILRB3 binding molecules and uses thereof
EP3387007A4 (fr) Molécules protéiques et procédés d'utilisation
IL280369A (en) Myokines and their uses
ZA201905544B (en) Modified haemoglobin proteins
GB201819125D0 (en) Biomarkers and uses thereof
EP3411061A4 (fr) Composés protéiques et leurs utilisations
HUP1700012A2 (en) Novel proteins and use thereof
AU2018900108A0 (en) Proteinaceous molecules and uses therefor
IL285585A (en) fcmr-binding molecules and their uses